14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $137.78 $156.84 Monday, 22nd Apr 2024 ASND stock ended at $142.10. This is 1.38% more than the trading day before Friday, 19th Apr 2024. During the day the stock fluctuated 2.74% from a day low at $140.48 to a day high of $144.33.
90 days $128.67 $161.00
52 weeks $66.03 $161.00

Historical Ascendis Pharma A/S prices

Date Open High Low Close Volume
Apr 22, 2022 $106.33 $108.10 $104.80 $105.92 304 100
Apr 21, 2022 $110.20 $110.83 $105.30 $106.05 446 000
Apr 20, 2022 $110.13 $110.80 $108.11 $109.59 167 700
Apr 19, 2022 $106.96 $111.11 $106.00 $109.78 238 800
Apr 18, 2022 $112.75 $112.75 $105.93 $107.15 943 200
Apr 14, 2022 $115.29 $115.29 $111.98 $112.96 372 419
Apr 13, 2022 $109.69 $115.52 $107.94 $115.52 352 336
Apr 12, 2022 $107.41 $110.65 $106.44 $108.84 640 640
Apr 11, 2022 $110.75 $110.87 $105.06 $106.34 316 303
Apr 08, 2022 $112.23 $115.41 $110.76 $111.21 299 827
Apr 07, 2022 $117.40 $119.94 $111.26 $114.28 512 400
Apr 06, 2022 $114.03 $119.07 $113.04 $117.61 398 300
Apr 05, 2022 $117.36 $120.34 $114.87 $115.73 363 300
Apr 04, 2022 $116.22 $120.69 $115.28 $117.40 255 400
Apr 01, 2022 $117.76 $119.68 $114.04 $115.92 476 689
Mar 31, 2022 $115.83 $118.93 $115.26 $117.28 439 926
Mar 30, 2022 $119.15 $123.03 $114.81 $116.14 296 733
Mar 29, 2022 $112.16 $120.48 $112.16 $119.40 529 400
Mar 28, 2022 $116.99 $116.99 $107.00 $111.35 479 200
Mar 25, 2022 $117.06 $117.50 $111.92 $114.39 2 425 900
Mar 24, 2022 $111.72 $122.01 $107.00 $116.73 1 869 300
Mar 23, 2022 $122.39 $122.96 $116.74 $117.14 237 500
Mar 22, 2022 $110.86 $125.88 $110.86 $123.34 450 436
Mar 21, 2022 $116.91 $126.79 $111.11 $111.58 327 044
Mar 18, 2022 $118.49 $121.04 $116.90 $117.44 500 348
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT